Humana (HUM) faced a series of events that have impacted its market performance. This includes a pessimistic forecast by Bank of America on its stock price and a reduction in Humana's price target by BofA. It also faced some major setbacks with their shares being significantly impacted and strategic opportunities being adjusted. Additionally, the company backed curbs to Medicare Advantage billing practices amidst a slump in the Medicare Advantage market. Despite the dips, Bernstein has maintained a positive outlook for Humana citing sector turnaround opportunities. In other news, Humana launched a campaign called 'Invite' to inspire active aging through leisure activities like pickleball. The company also plans to target a four-star Medicare rating by 2028. On the financial front, Truist Financial reiterates a '$280.00' price target for Humana and FNY Investment Advisers LLC holds a $95,000 stake in the company. Lastly, Humanaβs initiatives have improved health outcomes in communities it operates.
Humana HUM News Analytics from Wed, 02 Oct 2024 07:00:00 GMT to Sat, 21 Jun 2025 04:42:02 GMT -
Rating -2
- Innovation 0
- Information 5
- Rumor -5
